Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LRP2 Expression in Melanoma Is Associated With a Transitory Cell State, Increased T Cell Infiltration, and Is Upregulated by IFNy Signaling. | Pigment Cell Melanoma Res | 2025 | 40913277 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals Granzyme K+ CD8+ T Cells as a Target for Mitigating Plaque Instability Following Radiation. | J Am Heart Assoc | 2025 | 40913272 | PubTator, text mining | PubMed |
| Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids. | Commun Biol | 2025 | 40858992 | PubTator, text mining | PubMed |
| Investigating cytotoxic and inflammatory human IL-7 receptor low effector memory CD8+ T cells in lupus. | EBioMedicine | 2025 | 40857939 | PubTator, text mining | PubMed |
| The role of complement in long COVID pathogenesis. | JCI Insight | 2025 | 40857408 | PubTator, text mining | PubMed |
| Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles. | Exp Hematol Oncol | 2025 | 40855348 | PubTator, text mining | PubMed |
| Polyclonal expansion of functional tumor-reactive lymphocytes infiltrating glioblastoma for personalized cell therapy. | Nat Commun | 2025 | 40855052 | PubTator, text mining | PubMed |
| CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders. | J Immunol | 2025 | 40849886 | PubTator, text mining | PubMed |
| Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances. | J Exp Clin Cancer Res | 2025 | 40849493 | PubTator, text mining | PubMed |
| Multi-omics single-cell analysis reveals key regulators of HIV-1 persistence and aberrant host immune responses in early infection. | Elife | 2025 | 40838493 | PubTator, text mining | PubMed |
| Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer. | J Med Virol | 2025 | 40832845 | PubTator, text mining | PubMed |
| Immune dysregulation in the prostates of C57BL/6Aire-/- mice mirrors that seen in human benign prostatic hyperplasia. | bioRxiv | 2025 | 40832162 | PubTator, text mining | PubMed |
| The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers. | Biomark Res | 2025 | 40830526 | PubTator, text mining | PubMed |
| Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy. | J Immunother Cancer | 2025 | 40829901 | PubTator, text mining | PubMed |
| Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. | Cell Rep Med | 2025 | 40829595 | PubTator, text mining | PubMed |
| Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential. | Virulence | 2025 | 40825006 | PubTator, text mining | PubMed |
| Multimodal profiling reveals tissue-directed signatures of human immune cells altered with age. | Nat Immunol | 2025 | 40804529 | PubTator, text mining | PubMed |
| A cell type and state specific gene regulation network inference method for immune regulatory analysis. | NPJ Syst Biol Appl | 2025 | 40804307 | PubTator, text mining | PubMed |
| Microbiota Transplant Therapy Is Safe and Feasible in Pulmonary Arterial Hypertension. | JACC Basic Transl Sci | 2025 | 40803054 | PubTator, text mining | PubMed |
| Roles of hypoxia inducible factors in viral infection: Are they a potential therapeutic target? | Virulence | 2025 | 40802588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=9